Clinical trial

A Study of PF-07260437 in Advanced or Metastatic Solid Tumors

NCT05067972

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2021-10-07

PhasePHASE1

Study timeline

Study start (actual)2021-10-07Date precision: day

Registry last updated2025-05-06

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Ovarian Neoplasmsunresolved

Endometrial Neoplasmsunresolved

Breast Neoplasmsunresolved

Interventions

PF-07260437DRUG

B7-H4 IHCDIAGNOSTIC_TEST

Sponsors & collaborators

Pfizerlead sponsor

Mapped research locations

SeattleWashington, United States3 TampaFlorida, United States2 ChicagoIllinois, United States1 San AntonioTexas, United States1 The BronxNew York, United States1 DuarteCalifornia, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05067972 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.